Long Shortz with Optiscan Imaging: the future of pathology is here

Stockhead’s Fraser Palamara sits down with Managing Director of  Optiscan (ASX:OIL) Dr Camile Farah  to get the short end of the long story, on the company’s latest news.

Optiscan has unveiled its first-in-class, next-generation microscopic medical imaging device InForm.

In this video Camile chats to Fraser about how InForm could revolutionise traditional analogue pathology workflows through digitalisation and improve efficiency for greater speed to diagnosis.

This video was developed in collaboration with Optiscan, a Stockhead advertiser at the time of publishing.

The interviews and discussions in this video are opinions only and not financial or investment advice. Viewers should obtain independent advice based on their own circumstances before making any financial decisions.